These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 20523897)

  • 21. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
    Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
    J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection.
    Andersson J; Behbahani H; Lieberman J; Connick E; Landay A; Patterson B; Sönnerborg A; Loré K; Uccini S; Fehniger TE
    AIDS; 1999 Jul; 13(11):1295-303. PubMed ID: 10449281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
    Van Gulck E; Bracke L; Heyndrickx L; Coppens S; Atkinson D; Merlin C; Pasternak A; Florence E; Vanham G
    PLoS One; 2012; 7(5):e37792. PubMed ID: 22666392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals.
    Trabattoni D; Piconi S; Biasin M; Rizzardini G; Migliorino M; Seminari E; Boasso A; Piacentini L; Villa ML; Maserati R; Clerici M
    AIDS; 2004 Apr; 18(6):859-69. PubMed ID: 15060433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV.
    Boutboul F; Puthier D; Appay V; Pellé O; Ait-Mohand H; Combadière B; Carcelain G; Katlama C; Rowland-Jones SL; Debré P; Nguyen C; Autran B
    AIDS; 2005 Nov; 19(17):1981-6. PubMed ID: 16260904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.
    Betts MR; Nason MC; West SM; De Rosa SC; Migueles SA; Abraham J; Lederman MM; Benito JM; Goepfert PA; Connors M; Roederer M; Koup RA
    Blood; 2006 Jun; 107(12):4781-9. PubMed ID: 16467198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogen.
    Moss RB; Giermakowska WK; Wallace MR; Jensen FC; Maigetter RZ; Carlo DJ
    Clin Exp Immunol; 2001 May; 124(2):248-54. PubMed ID: 11422201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant expression of perforin and granzyme A in total and HIV-specific CD8 T lymphocytes of HIV infected children and adolescents.
    Haridas V; McCloskey TW; Pahwa R; Pahwa S
    AIDS; 2003 Nov; 17(16):2313-22. PubMed ID: 14571182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.
    Sáez-Cirión A; Lacabaratz C; Lambotte O; Versmisse P; Urrutia A; Boufassa F; Barré-Sinoussi F; Delfraissy JF; Sinet M; Pancino G; Venet A;
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6776-81. PubMed ID: 17428922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV Controllers Exhibit Effective CD8
    Monel B; McKeon A; Lamothe-Molina P; Jani P; Boucau J; Pacheco Y; Jones RB; Le Gall S; Walker BD
    Cell Rep; 2019 Apr; 27(1):142-153.e4. PubMed ID: 30943397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report: mechanisms of HIV elite control in two African women.
    Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
    BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic Restimulation of Virus-Specific Memory CD8
    Migueles SA; Rogan DC; Gavil NV; Kelly EP; Toulmin SA; Wang LT; Lack J; Ward AJ; Pryal PF; Ludwig AK; Medina RG; Apple BJ; Toumanios CN; Poole AL; Rehm CA; Jones SE; Liang CJ; Connors M
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential.
    Jo J; Bengsch B; Seigel B; Rau SJ; Schmidt J; Bisse E; Aichele P; Aichele U; Joeckel L; Royer C; Sá Ferreira K; Borner C; Baumert TF; Blum HE; Lohmann V; Fischer R; Thimme R
    J Hepatol; 2012 Jul; 57(1):9-16. PubMed ID: 22425625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.
    Tomescu C; Duh FM; Hoh R; Viviani A; Harvill K; Martin MP; Carrington M; Deeks SG; Montaner LJ
    AIDS; 2012 Sep; 26(15):1869-78. PubMed ID: 22874514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of CD96 surface molecule represents CD8⁺ T cells with dissimilar effector function during HIV-1 infection.
    Eriksson EM; Keh CE; Deeks SG; Martin JN; Hecht FM; Nixon DF
    PLoS One; 2012; 7(12):e51696. PubMed ID: 23272144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates With the Expression of CD57.
    Jensen SS; Tingstedt JL; Larsen TK; Brandt L; Gerstoft J; Kronborg G; Pedersen C; Fomsgaard A; Karlsson I
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):8-16. PubMed ID: 26761268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T cells in chronically infected patients: dual effects of highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Martinez P; Kuroda M; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):255-66. PubMed ID: 14600569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: concomitant assessment of perforin, IFN-gamma and IL-4 secretion.
    Burton CT; Gotch F; Imami N
    J Immunol Methods; 2006 Jan; 308(1-2):216-30. PubMed ID: 16388819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection.
    de Silva TI; Peng Y; Leligdowicz A; Zaidi I; Li L; Griffin H; Blais ME; Vincent T; Saraiva M; Yindom LM; van Tienen C; Easterbrook P; Jaye A; Whittle H; Dong T; Rowland-Jones SL
    Blood; 2013 May; 121(21):4330-9. PubMed ID: 23558015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.
    Crawford TQ; Hecht FM; Pilcher CD; Ndhlovu LC; Barbour JD
    PLoS One; 2013; 8(10):e77412. PubMed ID: 24143233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.